Optimized Hepatitis E Virus (HEV) Culture and Its Application to Measurements of HEV Infectivity - Université Toulouse III - Paul Sabatier - Toulouse INP Accéder directement au contenu
Article Dans Une Revue Viruses Année : 2020

Optimized Hepatitis E Virus (HEV) Culture and Its Application to Measurements of HEV Infectivity

Résumé

Hepatitis E virus (HEV) is a major concern in public health worldwide. Infections with HEV genotypes 3, 4, or 7 can lead to chronic hepatitis while genotype 1 infections can trigger severe hepatitis in pregnant women. Infections with all genotypes can worsen chronic liver diseases. As virions are lipid-associated in blood and naked in feces, efficient methods of propagating HEV clinical strains in vitro and evaluating the infectivity of both HEV forms are needed. We evaluated the spread of clinical strains of HEV genotypes 1 (HEV1) and 3 (HEV3) by quantifying viral RNA in culture supernatants and cell lysates. Infectivity was determined by endpoint dilution and calculation of the tissue culture infectious dose 50 (TCID50). An enhanced HEV production could be obtained varying the composition of the medium, including fetal bovine serum (FBS) and dimethylsulfoxide (DMSO) content. This increased TCID50 from 10 to 100-fold and allowed us to quantify HEV1 infectivity. These optimized methods for propagating and measuring HEV infectivity could be applied to health safety processes and will be useful for testing new antiviral drugs.
Fichier principal
Vignette du fichier
CapelliNicolas_2020.pdf (1.21 Mo) Télécharger le fichier
Origine Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-03167792 , version 1 (12-03-2021)

Identifiants

Citer

Nicolas Capelli, Martine Dubois, Mélanie Pucelle, Isabelle da Silva, Sébastien Lhomme, et al.. Optimized Hepatitis E Virus (HEV) Culture and Its Application to Measurements of HEV Infectivity. Viruses, 2020, 12 (2), pp.139-148. ⟨10.3390/v12020139⟩. ⟨hal-03167792⟩
40 Consultations
38 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More